Black Rock Inc. Ocugen, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
119Shares Held
75.2MCall Options Held
200KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA16.7MShares$16.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$6.68 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$5.75 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.24 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.03 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $210M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...